OPCH counsel receives 15,213-share stock grant

Option Care Health, Inc. reported that General Counsel and Corporate Secretary Collin Smyser acquired 15,213 shares of common stock through an equity award coded as a grant or other acquisition.

Rhea-AI Filing Summary

Option Care Health, Inc. reported that General Counsel and Corporate Secretary Collin Smyser acquired 15,213 shares of common stock through an equity award coded as a grant or other acquisition. The award consists of restricted stock units that vest in three equal installments on each of the first, second, and third anniversaries of the grant date.

After this grant, Smyser directly owns 94,215 shares of common stock. In addition, 2,500 shares are held indirectly through a revocable trust, reflecting separate indirect ownership.

Insider Trade Summary

Grant/Award: 15,213 shares

Grant/Award 2 txns

Insider Smyser Collin

Role GC & Corporate Secretary

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	15,213	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 94,215 shares (Direct); Common Stock — 2,500 shares (Indirect, By Revocable Trust)

Footnotes (1)

1. F1. The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OPCH executive Collin Smyser report on this Form 4?

Collin Smyser reported an acquisition of 15,213 shares of Option Care Health common stock through a grant or award. The transaction was coded as an acquisition, indicating equity compensation rather than an open-market purchase of shares.

How do the newly granted OPCH restricted stock units vest for Collin Smyser?

The restricted stock units granted to Collin Smyser vest in three equal installments. One third of the underlying common shares vest on each of the first, second, and third anniversaries of the grant date, creating a multi-year retention schedule.

How many OPCH shares does Collin Smyser hold directly after this Form 4 transaction?

Following the reported equity award, Collin Smyser directly owns 94,215 shares of Option Care Health common stock. This figure reflects his direct holdings after the 15,213-share grant was added to his existing position in the company.

Does Collin Smyser have any indirect ownership of OPCH shares?

Yes. In addition to his direct holdings, 2,500 Option Care Health shares are held indirectly by a revocable trust. The Form 4 identifies this position as indirect ownership, separate from the shares he holds in his own name.

Was the OPCH Form 4 transaction an open-market buy or a compensation grant?

The Form 4 describes the transaction as a grant, award, or other acquisition rather than an open-market buy. The zero-dollar price and vesting schedule indicate equity compensation through restricted stock units, not a cash purchase on the open market.

What role does Collin Smyser hold at Option Care Health (OPCH)?

Collin Smyser serves as General Counsel and Corporate Secretary at Option Care Health. His Form 4 filing reflects equity compensation tied to this executive role, aligning part of his pay with the company’s common stock performance over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 07:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smyser Collin

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC & Corporate Secretary

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		A		15,213(1)	A	$0	94,215	D
Common Stock								2,500	I	By Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date.

	/s/ Michael Bavaro, attorney-in-fact for Mr. Smyser	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.